Investigational Drug Details
| Drug ID: | D444 |
| Drug Name: | Amisulpride |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB06288 |
| DrugBank Description: | Amisulpride (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist. |
| PubChem ID: | 2159 |
| CasNo: | 71675-85-9 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC |
| Structure: |
|
| InChiKey: | NTJOBXMMWNYJFB-UHFFFAOYSA-N |
| Molecular Weight: | 369.479 |
| DrugBank Targets: | 5-hydroxytryptamine receptor 7; 5-hydroxytryptamine receptor 2A; Dopamine D2 receptor; Dopamine D3 receptor; Mu-type opioid receptor; Delta-type opioid receptor; Kappa-type opioid receptor |
| DrugBank MoA: | Amisulpride binds selectively to dopamine D(2) and D(3) receptors in the limbic system. Low doses of amisulpride preferentially block presynaptic D(2)/D(3)-dopamine autoreceptors, thereby enhancing dopaminergic transmission, whereas higher doses block postsynaptic receptors, thus inhibiting dopaminergic hyperactivity. It may also have 5-ht7 antagonistic effect, useful in depression treatment. |
| DrugBank Pharmacology: | |
| DrugBank Indication: | Investigated for use/treatment in schizophrenia and schizoaffective disorders, mania in bipolar disorder, and depression. |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L2082 | NCT01574820 | PHASE3 | COMPLETED | NO | 2006-11 | 2012-04-11 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|